source
- Be Bio halts hemophilia B cell-editing therapy trialBe Bio announced that it has terminated its clinical study of a hemophilia B therapy that used gene-editing of a patient’s own cells. The termination was recorded in a federal clinical-trials regi…
- U.S. infant mortality hits record low in 2025, though still behind peer nationsPreliminary CDC data show the United States recorded its lowest infant mortality rate ever in 2025. The rate fell to just under 5.4 deaths per 1,000 live births. That figure represents a modest de…